4.3 Article

2013 White Paper on recent issues in bioanalysis: 'hybrid' - the best of LBA and LCMS

期刊

BIOANALYSIS
卷 5, 期 23, 页码 2903-2918

出版社

FUTURE SCI LTD
DOI: 10.4155/bio.13.238

关键词

-

资金

  1. US FDA
  2. Europe EMA
  3. Health Canada
  4. Netherlands MEB
  5. Brazil ANVISA
  6. Japan MHLW
  7. UK MHRA

向作者/读者索取更多资源

The 2013 7th Workshop on Recent Issues in Bioanalysis was held in Long Beach, California, USA, where close to 500 professionals from pharmaceutical and biopharmaceutical companies, CROs and regulatory agencies convened to discuss current topics of interest in bioanalysis. These hot' topics, which covered both small and large molecules, were the starting point for fruitful exchanges of knowledge, and sharing of ideas among speakers, panelists and attendees. The discussions led to specific recommendations pertinent to bioanalytical science. Such as the previous editions, this 2013 White Paper addresses important bioanalytical issues and provides practical answers to the topics presented, discussed and agreed upon by the global bioanalytical community attending the 7th Workshop on Recent Issues in Bioanalysis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据